Skip to main content
Fig. 4 | BMC Endocrine Disorders

Fig. 4

From: Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study

Fig. 4

Median HbA1c and BMI and confidence intervals by intensification group over time: metformin+ insulin (Panel a); switch to insulin monotherapy (Panel b). Patients are allocated into these drug treatment exposures at treatment intensification persistence on medication is not required. Confidence intervals were calculated using the maximum Harrell-Davis standard error

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us